Larimar Therapeutics, Inc. (LRMR) NASDAQ
4.08
-0.05(-1.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.08
-0.05(-1.21%)
Currency In USD
| Market Cap | 277.93M |
| Enterprise Value | 196.59M |
| P/E Ratio | -2.09 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.43 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.14 |
| Return On Equity | -1.38 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -350,000 |
| EBITDA | -172.5M |
| Net Income | -165.67M |
| Diluted EPS | -2.27 |
| Total Cash | 136.85M |
| Total Cash/Share | 1.61 |
| Total Debt | 4.07M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.19 |
| Book Value Per Share | 0.92 |
| 52-Week Change | 115.96 |
| 52-Week High | 6.42 |
| 52-Week Low | 1.73 |
| Moving Average 50 Days | 4.66 |
| Moving Average 200 Days | 4.02 |
| Average Volume | 4.44M |
| Shares Outstanding | 85.58M |
| % Held by Institutions | 92.47 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | May 29, 2020 |